Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Tumescent Solution for Liposuction
NCT06648265Phase 4Completed
- Sponsor
- Total Definer Research Group
- Start
- Jan 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in ecchymosis, post-operative inflammation, sponsored by Total Definer Research Group. Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
ecchymosispost-operative inflammation
Beyond the preview
Go deeper on NCT06648265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648265.